Label: DR. PIERCING AFTERCARE MEDICATION- benzalkonium chloride spray

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated March 28, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    BENZALKONIUM CHLORIDE 0.11%

  • PURPOSE

    ANTISEPTIC

  • USES

    FOR CLEANING PIERCINGS AND MINOR WOUNDS.

  • DIRECTIONS

    • TWIST THE CAP TO UNLOCK
    • BEFORE USE, SPRAY IN AIR OR AWAY FROM WOUND TO TEST FLOW AND CLEAN NOZZLE HEAD
    • TO APPLY, AIM NOZZLE AT AREA OF INTEREST FROM DESIRED DISTANCE AND SPRAY UNTIL DESIRED AMOUNT IS APPLIED
  • WARNINGS

    • DO NOT USE IF TAMPER BAN IS REMOVED
    • DO NOT USE IN BODY ORIFICES, EAR CANALAS OR EYES.
    • CONSULT A HEALTHCARE PROFESSIONAL FOR CONTINUED WOUND CARE AND FOR USE ON CHILDREN
    • IF SWELLING, REDNESS OR PAIN INCREASES, PLEASE SEEK THE ADVICE OF YOUR HEALTHCARE PROFESSIONAL
    • STORE IN A COOL ENVIRONMENT AT 59 F TO 86 F AND PROTECTED FROM SUNLIGHT
    • CONTENT UNDER PRESSURE
    • FOR EXTERNAL USE ONLY
  • KEEP OUT OF REACH OF CHILDREN

    KEEP OUT OF REACH OF CHILDREN

  • OTHER INGREDIENTS

    CAPB, ISOTONIC SALINE SOLUTION, SODIUM CHLORIDE, ALLANTOIN, ALOE VERA, KATHHOC CG II, PRO-VITAMIN B5, TRIETHANOLAMINE

  • PRINCIPAL DISPLAY PANEL

    01b LBL_Dr. Piercing Aftercare 45x125_Spray_PR_OT_FinalX

  • INGREDIENTS AND APPEARANCE
    DR. PIERCING AFTERCARE MEDICATION 
    benzalkonium chloride spray
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:81926-101
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) BENZALKONIUM CHLORIDE0.11 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    ISOTONIC SODIUM CHLORIDE SOLUTION (UNII: VR5Y7PDT5W)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PANTOTHENIC ACID (UNII: 19F5HK2737)  
    TROLAMINE (UNII: 9O3K93S3TK)  
    COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)  
    ALLANTOIN (UNII: 344S277G0Z)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    METHYLCHLOROISOTHIAZOLINONE/METHYLISOTHIAZOLINONE MIXTURE (UNII: 15O9QS218W)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:81926-101-7474 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product08/04/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00308/04/2022
    Labeler - Broadway Products LLC (002672936)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!